Moreover, combination treatment with DNA demethylating agents and HDAC inhibitors were used to increase thyroid-specific gene expression and restore RAI therapy effectiveness in thyroid cancer (Table 2) 156, 157. The gene discussed is HDAC9; the disease is thyroid cancer.